Perfluorooctanoic acid alters progesterone activity in human endometrial cells and induces reproductive alterations in young women.


Journal

Chemosphere
ISSN: 1879-1298
Titre abrégé: Chemosphere
Pays: England
ID NLM: 0320657

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 23 08 2019
revised: 10 10 2019
accepted: 23 10 2019
entrez: 4 1 2020
pubmed: 4 1 2020
medline: 25 2 2020
Statut: ppublish

Résumé

Female fecundity is finely regulated by hormonal signaling, representing a potential target for endocrine-disrupting chemicals. Among the chemicals of most concern are the perfluoroalkyl substances (PFAS), widely used in consumer goods, that are associated with adverse effects on reproductive health. In this context, the endometrium clearly represents an important fertility determining factor. The aim of this study was to investigate PFAS interference on hormonal endometrial regulation. This study was performed within a screening protocol to evaluate reproductive health in high schools. We studied a cohort of 146 exposed females aged 18-21 from the Veneto region in Italy, one of the four areas worldwide heavily polluted with PFAS, and 1080 non-exposed controls. In experiments on Ishikawa cells included UV-Vis spectroscopy, microarray analysis and qPCR. We report a significant dysregulation of the genetic cascade leading to embryo implantation and endometrial receptivity. The most differentially-expressed genes upon PFOA coincubation were ITGB8, KLF5, WNT11, SULT1E1, ALPPL2 and G0S2 (all p < 0.01). By qPCR, we confirmed an antagonistic effect of PFOA on all these genes, which was reversed at higher progesterone levels. Molecular interference of PFOA on progesterone was confirmed by an increase in the intensity of absorption spectra at 250 nm in a dose-dependent manner, but not in the presence of β-estradiol. Age at menarche (+164 days, p = 0.006) and the frequency of girls with irregular periods (29.5% vs 21.5%, p = 0.022) were significantly higher in the exposed group. Our results are indicative of endocrine-disrupting activity of PFAS on progesterone-mediated endometrial function.

Identifiants

pubmed: 31896193
pii: S0045-6535(19)32448-8
doi: 10.1016/j.chemosphere.2019.125208
pii:
doi:

Substances chimiques

Caprylates 0
Endocrine Disruptors 0
Environmental Pollutants 0
Fluorocarbons 0
Progesterone 4G7DS2Q64Y
Estradiol 4TI98Z838E
perfluorooctanoic acid 947VD76D3L
Sulfotransferases EC 2.8.2.-
estrone sulfotransferase EC 2.8.2.4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

125208

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

A Di Nisio (A)

Department of Medicine, Operative Unit of Andrology and Medicine of Human Reproduction, University of Padova, Via Giustiniani, 2, 35128, Padova, Italy.

M S Rocca (MS)

Familial Cancer Clinic, Veneto Institute of Oncology (IOV-IRCSS), 35128, Padova, Italy.

I Sabovic (I)

Department of Medicine, Operative Unit of Andrology and Medicine of Human Reproduction, University of Padova, Via Giustiniani, 2, 35128, Padova, Italy.

M De Rocco Ponce (M)

Department of Medicine, Operative Unit of Andrology and Medicine of Human Reproduction, University of Padova, Via Giustiniani, 2, 35128, Padova, Italy.

C Corsini (C)

Department of Medicine, Operative Unit of Andrology and Medicine of Human Reproduction, University of Padova, Via Giustiniani, 2, 35128, Padova, Italy.

D Guidolin (D)

Department of Neurosciences, University of Padova, Via Gabelli 65, 35128, Padova, Italy.

C Zanon (C)

Istituto di Ricerca Pediatrica (IRP) - Fondazione Città della Speranza, Corso Stati Uniti 4, Padova, Italy.

L Acquasaliente (L)

Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine 1100 South Grand Blvd. St. Louis, MO, 63104, USA.

A R Carosso (AR)

Department of Surgical Sciences, Gynecology and Obstetrics 1, Physiopathology of Reproduction and IVF Unit, S. Anna Hospital, University of Torino, 10126, Torino, Italy.

L De Toni (L)

Department of Medicine, Operative Unit of Andrology and Medicine of Human Reproduction, University of Padova, Via Giustiniani, 2, 35128, Padova, Italy.

C Foresta (C)

Department of Medicine, Operative Unit of Andrology and Medicine of Human Reproduction, University of Padova, Via Giustiniani, 2, 35128, Padova, Italy. Electronic address: carlo.foresta@unipd.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH